{"log_id": 4906149246848249167, "direction": 0, "words_result_num": 32, "words_result": [{"probability": {"variance": 2e-06, "average": 0.998186, "min": 0.996209}, "location": {"width": 66, "top": 266, "height": 25, "left": 487}, "words": "试验组"}, {"probability": {"variance": 5.8e-05, "average": 0.993045, "min": 0.982411}, "location": {"width": 25, "top": 307, "height": 67, "left": 184}, "words": "存活率"}, {"probability": {"variance": 4.7e-05, "average": 0.995945, "min": 0.984122}, "location": {"width": 93, "top": 422, "height": 25, "left": 352}, "words": "安慰剂组"}, {"probability": {"variance": 0.000188, "average": 0.984547, "min": 0.970851}, "location": {"width": 20, "top": 601, "height": 20, "left": 792}, "words": "20"}, {"probability": {"variance": 2.2e-05, "average": 0.996399, "min": 0.987033}, "location": {"width": 108, "top": 598, "height": 23, "left": 914}, "words": "25(月)"}, {"probability": {"variance": 0.000613, "average": 0.987939, "min": 0.927611}, "location": {"width": 157, "top": 631, "height": 28, "left": 546}, "words": "随机后的时间点"}, {"probability": {"variance": 0.007049, "average": 0.953803, "min": 0.672117}, "location": {"width": 676, "top": 687, "height": 33, "left": 245}, "words": "图1.Ⅲ1期研究中两组生存期(OS,月)的疗效对比分析(FAS集)"}, {"probability": {"variance": 0.000125, "average": 0.995716, "min": 0.948135}, "location": {"width": 946, "top": 766, "height": 44, "left": 165}, "words": "另外一项多中心、随机、双盲、安慰剂平行对照的Ⅱ期临床研究同样以二线化疗失败的晚"}, {"probability": {"variance": 0.000124, "average": 0.994231, "min": 0.94214}, "location": {"width": 995, "top": 814, "height": 45, "left": 117}, "words": "期胃癌患者为受试对象,共入组141例受试者,其中安慰剂组48例、850mgqd组47例、425mg"}, {"probability": {"variance": 0.000438, "average": 0.992253, "min": 0.864255}, "location": {"width": 992, "top": 861, "height": 46, "left": 120}, "words": "bd组46例,28天为一个周期,主要终点指标为无进展生存期。结果:850mgqd组患者的中"}, {"probability": {"variance": 0.002258, "average": 0.986385, "min": 0.76905}, "location": {"width": 997, "top": 908, "height": 47, "left": 117}, "words": "位无进展生存期为3.7个月,425 mg bid组患者为3.2个月,与安慰剂组相比差异均有统计学意"}, {"probability": {"variance": 0.000693, "average": 0.988591, "min": 0.873346}, "location": {"width": 994, "top": 956, "height": 45, "left": 120}, "words": "义(P<0.0001)。两试验组患者的中位生存期、客观缓解率均高于安慰剂组。表4列出了主要"}, {"probability": {"variance": 0, "average": 0.999342, "min": 0.998355}, "location": {"width": 124, "top": 1019, "height": 29, "left": 119}, "words": "有效性数据"}, {"probability": {"variance": 0.000622, "average": 0.988245, "min": 0.908285}, "location": {"width": 458, "top": 1068, "height": 34, "left": 412}, "words": "表4.Ⅱ期临床研究的主要有效性结果(FAS集)"}, {"probability": {"variance": 0, "average": 0.999722, "min": 0.999549}, "location": {"width": 49, "top": 1123, "height": 27, "left": 361}, "words": "指标"}, {"probability": {"variance": 0.005949, "average": 0.951756, "min": 0.699729}, "location": {"width": 393, "top": 1116, "height": 30, "left": 617}, "words": "850mgqd组(N=47)安慰剂组(N=48"}, {"probability": {"variance": 0.008369, "average": 0.949111, "min": 0.671133}, "location": {"width": 197, "top": 1169, "height": 27, "left": 196}, "words": "无进展生存期(PHS)"}, {"probability": {"variance": 0.018165, "average": 0.926918, "min": 0.567163}, "location": {"width": 200, "top": 1207, "height": 32, "left": 234}, "words": "中位数(mPFS,月)"}, {"probability": {"variance": 0, "average": 0.990807, "min": 0.990807}, "location": {"width": 15, "top": 1205, "height": 19, "left": 925}, "words": "1"}, {"probability": {"variance": 0.021357, "average": 0.923558, "min": 0.597409}, "location": {"width": 112, "top": 1256, "height": 21, "left": 234}, "words": " HR(95% CI"}, {"probability": {"variance": 0.000246, "average": 0.988629, "min": 0.937126}, "location": {"width": 178, "top": 1247, "height": 23, "left": 726}, "words": "0.232(0.133,0.406)"}, {"probability": {"variance": 0.006321, "average": 0.945759, "min": 0.819078}, "location": {"width": 147, "top": 1295, "height": 28, "left": 192}, "words": "总生存期(OS"}, {"probability": {"variance": 0.022229, "average": 0.921909, "min": 0.543773}, "location": {"width": 190, "top": 1335, "height": 28, "left": 235}, "words": "中位数(mos,月)"}, {"probability": {"variance": 0.000161, "average": 0.990341, "min": 0.972386}, "location": {"width": 31, "top": 1333, "height": 20, "left": 693}, "words": "4.8"}, {"probability": {"variance": 0.001479, "average": 0.960903, "min": 0.922439}, "location": {"width": 17, "top": 1330, "height": 19, "left": 928}, "words": "2."}, {"probability": {"variance": 0.001581, "average": 0.975513, "min": 0.887816}, "location": {"width": 106, "top": 1381, "height": 23, "left": 237}, "words": " HR(95% CI"}, {"probability": {"variance": 0.001545, "average": 0.986307, "min": 0.830767}, "location": {"width": 177, "top": 1372, "height": 23, "left": 729}, "words": "0.513(0.319,0.826"}, {"probability": {"variance": 0.002629, "average": 0.970785, "min": 0.816032}, "location": {"width": 213, "top": 1420, "height": 29, "left": 195}, "words": "客观缓解率(CR+PR)"}, {"probability": {"variance": 6e-06, "average": 0.99428, "min": 0.991896}, "location": {"width": 31, "top": 1415, "height": 20, "left": 743}, "words": "8%"}, {"probability": {"variance": 0.002936, "average": 0.969955, "min": 0.805791}, "location": {"width": 254, "top": 1462, "height": 28, "left": 196}, "words": "临床获益率(CR+PR+SD)"}, {"probability": {"variance": 0.0002, "average": 0.991333, "min": 0.959888}, "location": {"width": 66, "top": 1459, "height": 21, "left": 716}, "words": "51.06%"}, {"probability": {"variance": 0.001509, "average": 0.977621, "min": 0.891239}, "location": {"width": 64, "top": 1456, "height": 20, "left": 915}, "words": "10.42%"}], "language": 3}